Drug Type Small molecule drug |
Synonyms acrivastina |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date GB (17 Sep 1997), |
Regulation- |
Molecular FormulaC22H24N2O2 |
InChIKeyPWACSDKDOHSSQD-IUTFFREVSA-N |
CAS Registry87848-99-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02760 | Acrivastine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Allergic skin reaction | CN | 27 May 2000 | |
Dermatographic urticaria | CN | 27 May 2000 | |
Eczema | CN | 27 May 2000 | |
Rhinitis, Allergic, Seasonal | CN | 27 May 2000 | |
Chronic Urticaria | GB | 17 Sep 1997 | |
Rhinitis, Allergic | GB | 17 Sep 1997 |